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A(A2)AR = adenosine receptor 
BM = bone marrow 
CEACAM = carcinoembryonic antigen-related cell adhesion molecule 
Csk = C-terminal Scr kinase 
fMLF = formyl-methionyl-leucyl phenylalanine peptide 
GAP = GTPase activating proteins 
GEF = guanine nucleotide exchange factor 
G-CSF = Granulocyte colony stimulating factor 
G-CSFR = Granulocyte colony stimulating factor receptor 
GPCR = G protein coupled receptor 
GRK = G protein coupled receptor kinase 
IBD = Inflammatory bowel disease 
ICAM-1 = Intracellular Adhesion molecule-1 
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IL = interleukin 
InsP6 = Inositol hexakisphosphate 
ITAM = immunoreceptor tyrosine-based activation motif 
ITIM = immunoreceptor tyrosine-based inhibitor motif 
JAK = Janus kinase 
LFA-1 = lymphocyte function-associated antigen-1  
LPS = lipopolysaccharide 
LTB4 = leukotriene B4 
NADPH = Nicotinamide adenine dinucleotide phosphate 
NETs = Nuclear extracellular traps 
MPO = myeloperoxidase 
PI3K = phosphoinositide 3-kinase 
PIAS = protein inhibitor of activated STAT 
PILRα = paired immunoglobulin-like type 2 receptor-α 
PIR-B = paired immunoglobulin receptor 
PMN = polymorphonuclear neutrophils 
PNCA = proliferating cell nuclear antigen 
PtdIns(3,4,5)P3 = Phosphatidylinositol 3,4,5-triphosphate 
PtdIns(3,4)P2 = Phosphatidylinositol 3,4-biphosphate 
PTEN = Phosphatase and tensin homolog 
PTP1B = protein-tyrosine phosphatase 1B 
PTPN6 = Tyrosine-protein phosphatase non-receptor type 6; also known as SHP-1 in 
humans 
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ROS = reactive oxygen species 
SDF-1 = stromal derived factor 
SHIP-1 = SH2 domain-containing inositol phosphatase-1 
SHP = SH2 domain-containing phosphatase 
Siglecs = Sialic acid binding Ig-like lectins 
SIRP-α = Signal regulatory protein-α 
SLE = systemic lupus erythematosus 
SOCS3 = suppressor of cytokine signaling-3 
STAT = signal transducer and activator of transcription 
WHIM = warts, hypogammaglobulinemia, infections, myelokathesis 
Wip-1 =Wild-Type p53-induced phosphatase 1 
WT = wild type 
Abstract 
 
Polymorphonuclear neutrophils (PMN) play a critical role in host defense against infection 
and in the resolution of inflammation. However immune responses mediated by PMN must 
be tightly regulated to facilitate elimination of invading pathogens without inducing 
detrimental inflammation and host tissue damage. Specific engagement of cell surface 
immunoreceptors by a diverse range of extracellular signals regulates PMN effector 
functions through differential activation of intracellular signaling cascades. While 
mechanisms of PMN activation mediated via cell signaling pathways have been well 
described less is known about negative regulation of PMN function by immune signaling 
cascades. Here we provide an overview of immunoreceptor mediated negative regulation of 
key PMN effector functions including maturation, migration, phagocytosis, ROS release, 
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degranulation, apoptosis and NETosis. Increased understanding of mechanisms of 
suppression of PMN effector functions may point to possible future therapeutic targets for 
the amelioration of PMN-mediated autoimmune and inflammatory diseases.  
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Introduction 
Polymorphonuclear neutrophils (PMN) are the predominant leukocytes in human 
blood and as such they are key effectors of the innate immune response. The highly motile 
nature of PMN paired with their ability to identify and rapidly respond to chemoattractant 
signals makes them critical first responders at sites of infection/inflammation. Following 
migration into inflamed tissues PMN execute a number of effector functions that facilitate 
pathogen clearance and resolution of inflammation including phagocytosis, generation of 
reactive oxygen metabolites, as well as release of microbiocidal granule contents and 
extracellular traps. However, the considerable array of microbiocidal and pro-inflammatory 
mediators contained within PMN granules means that excessive PMN accumulation and 
activation within inflamed tissues can be detrimental to the host [1, 2]. As such, PMN 
mediated mucosal tissue damage is a pathological consequence of a number of 
inflammatory disorders including inflammatory bowel disease (IBD), chronic obstructive 
pulmonary disorder (COPD), chronic peritonitis, sepsis and renal injury [3].  
Given the destructive potential of PMN in tissues, maturation, recruitment and 
inflammatory effector functions of PMN must be tightly regulated processes subjected to 
both positive and negative regulators. Such control is achieved in part through engagement 
of PMN cell surface receptors that trigger very diverse signal transduction pathways. PMN 
express several classes of cell surface receptors including G-protein-coupled-seven-
transmembrane receptors (GPCR), integrins, selectins, Fc receptors, cytokine receptors and 
innate immune receptors including C-type lectins and toll like receptors [4]. While 
engagement of cell surface receptors activates a range of PMN immune functions, it is also 
well accepted that PMN express various inhibitory receptors that negatively regulate critical 
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effector functions. This suppression of PMN activation serves to facilitate host protection 
from pathogens while avoiding bystander tissue damage and, as such is of critical 
importance for a successful immune response. Therefore, this mini-review highlights the 
regulation of PMN behavior through negative regulation of immune signaling pathways. 
 
Negative Regulation of PMN granulopoiesis 
The production and maturation of PMN (granulopoiesis) occurs in the bone marrow 
(BM) through sequential differentiation of hematopoietic stem cells to myeloblast, 
promyelocytes, myelocytes, metamyelocytes, band cells, and finally mature PMN. At the end 
of this process PMN leave the BM and begin circulating in the vasculature [5]. Granulocyte 
colony stimulating factor (G-CSF) is the major cytokine that induces granulopoiesis. 
However, G-CSF binding to its receptor G-CSFR also recruits several cytoplasmic tyrosine 
kinases, including members of the Src family kinases that function to negatively regulate 
PMN release from the BM. As such, triple knockout (KO) mice lacking Hck, Lyn, and Fgr, the 
major Src kinases expressed in myeloid cells, have an increased proliferative response to G-
CSF and more circulating PMN as compared to wild-type mice [6]. The analysis of individual 
roles for Hck and Lyn revealed that Hck negatively regulates G-CSF-induced proliferation of 
granulocytic precursors, whereas Lyn negatively regulates the production of myeloid 
progenitors [6]. 
 It has also been described that the suppressor of cytokine signaling-3 (SOCS3) 
inhibits G-CSFR signaling by a classical negative feedback loop mechanism. Activation of G-
CSFR results in recruitment of SOCS3 which binds directly to tyrosine Y729 on G-CSFR 
inhibiting JAK/STAT3 activation and thus regulating G-CSF mediated PMN proliferation [7]. 
In addition to inhibiting G-CSFR signaling, SOCS3 also inhibits IL-6 signaling by binding the 
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signal transducing receptor subunit gp130, a receptor that is closely related to G-CSFR [7]. 
Boyle et al. showed that mice expressing a truncated SOCS3 protein (lacking the C-terminal 
SOCS box) had an increased number of colony-forming cells upon exposure to G-CSF and 
IL-6. In an in vivo model of arthritis, truncation of SOCS3 leads to a more florid arthritis when 
compared with WT mice, suggesting that dysregulated PMN proliferation in the BM is 
associated with the development of autoimmune disorders [8].  
During PMN differentiation, progenitor cells committed to hematopoietic lineages 
interact and migrate along and then across BM while receiving stimulatory and inhibitory 
signals from stromal marrow cells. It is known that constitutive expression of stromal-derived 
factor (SDF-1/CXCL12) and its G protein-coupled chemokine receptor (CXCR4) are required 
for hematopoietic cell adhesion, and PMN retention in the BM [9]. In contrast, release of 
PMN occurs through CXCL2 (MIP-2) interaction with its receptor CXCR2, or through G-
CSFR or Toll-like receptors, all of which appear late during PMN maturation in the BM [10]. 
Consequently, mature PMN up-regulate expression of CXCR2 and decrease CXCR4 
expression, a balance that favors release of BM PMN into the circulation [11]. CXCR2, is a 
chemokine receptor that has been shown to favor PMN release and as such, Cxcr2-/- PMN 
fail to exit the BM, reproducing a myelokathexis phenotype. G-CSF decreases CXCL12 
expression in the BM, decreases PMN CXCR4 expression and, induces BM expression of 
the CXCR2 ligand CXCL2, ultimately promoting PMN release into the circulation [12]. 
CXCR4 on the other hand, opposes the role of CXCR2. Therefore mutations causing 
increased activation of CXCR4 result in increased PMN retention in the BM as seen in the 
human syndrome WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) [13]. 
Conversely, the deletion of CXCR4 in myeloid cells promotes a substantial neutrophilia [14]. 
Therefore, CXCL2-CXCR2 signaling represents a chemokine axis that controls PMN 
migration out of the BM by opposing CXCL12-CXCR4 signals [11]. PMN release may be 
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also be mediated by signals through G-CSFR, fMLF receptors or Toll-like receptors, but in 
the absence of CXCR4, the stimulation of these receptors does not cause additional PMN 
release from the BM, demonstrating the essential role of CXCR4 signaling for PMN retention 
in the BM [14].  
The adhesion and retention of PMN precursors within the BM depends on 1 and 2 
integrins interacting with their receptors expressed on stromal marrow cells. However, the 
exact mechanisms by which attenuated CXCR4 signaling leads to migration of PMN from 
the BM are not yet completely understood. The Src family kinases Lyn, Fgr, and Hck have 
been shown to play an essential role in integrin function and signaling in PMN. Of particular 
interest, Lyn has been shown to act as a negative regulator of PMN functions and it is an 
important part of the regulatory network that links chemotactic signals to adhesive responses 
of hematopoietic cells [15]. Nakata et al. showed that Lyn negatively regulates CXCL12-
CXCR4 mediated PMN adhesion to BM [16]. Activation of Lyn by CXCL12-CXCR4 inhibits 
activation of the β2 integrin LFA-1, reducing adhesion to intercellular adhesion molecule-1 
(ICAM-1) and allowing PMN to move more freely within the marrow, where they continue 
their maturation before being released into the circulation [16]. In vitro assays showed that 
PMN deficient in Lyn express normal levels of integrins (including LFA-1), but demonstrate 
increased attachment to BM stromal cells and decreased migration in response to CXCL12. 
Most probably this transient Lyn mediated inhibition of CXCR4-2 integrin activation occurs 
via inside-out signaling through as yet unidentified pathways. This negative regulation is not 
solely activated by the CXCR4 receptor as fMLF-induced PMN chemotaxis also requires Lyn 
to inhibit 2 integrin-dependent cell adhesion to ICAM-1 [16]. 
GPCRs involved in PMN proliferation and maturation in the BM are regulated by the 
activity of downstream kinases. As such, members of the GPCR kinase (GRK) and arrestin 
families induce GPCR desensitization upon agonist stimulation leading to a feedback 
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mechanism that rapidly uncouples the receptor from its associated G protein. There are 
seven GRKs known, with GRK2, -3, -5, and -6 being the four most widely expressed 
members. Studies from Grk6-deficient mice suggest GRK6 inhibits CXCL12-induced 
chemotaxis of PMN [17, 18]. Balabanian et al. also described a pivotal role for GRK3 in 
CXCR4 mediated signaling through internalization and desensitization of CXCR4 in 
fibroblasts and T cells. CD4+ T cells from WHIM syndrome patients displayed a stronger 
chemotaxis in response to CXCL12 [19]. However, the role of GRK3 and GRK6 in regulating 
PMN mobilization from BM into blood in response to CXCL12-CXCR4 has not been fully 
characterized.  
In addition to negative regulation of PMN maturation by protein kinases, 
granulopoiesis is also suppressed by protein phosphatases. Wild-Type p53-induced 
phosphatase 1 (Wip1, also known as PP2Cd) is an oncogene that inhibits several p53-
dependent tumor suppressor pathways. Expression of Wip1 increases during PMN 
maturation and, Wip1 deficient mice display increased granulocytic differentiation, 
proliferation, and BM maturation leading to a severe neutrophilia, suggesting that Wip1 is a 
negative regulator of both granulopoiesis and PMN homeostasis [20]. Further, in response to 
G-CSF, BM PMN deficient in Wip1 displayed rapid and increased phosphorylation of p38 
MAPK and STAT1 suggesting that Wip1 inhibits p38 MAPK/STAT1 mediated PMN 
maturation [20]. Another possible explanation for the neutrophilia observed in Wip1-/- mice is 
that Wip1 deficient PMN express higher levels of CXCR2 and lower levels of CXCR4 than 
wild type mice, thus favoring the release of PMN into the circulation [11]. 
 
Signaling events that inhibit PMN trafficking to sites of infection/inflammation  
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 PMN migration to inflamed mucosal tissues requires sequential migration across 
endothelial [21] and epithelial [1] barriers and is facilitated through a complicated series of 
protein-protein binding interactions. Trafficking of mature circulating PMN to sites of infection 
or inflammation is essential for effective defense against invading pathogens and for 
successful resolution of inflammation. However, given that PMN carry an arsenal of toxic 
metabolites that can cause damage to host tissues, all steps of the PMN trafficking cascade 
are highly regulated. While protein kinases such as Syk and Src family members mediate 
PMN activation through immunoreceptor tyrosine-based activation motif (ITAM) signaling 
domains, Src family members also activate immunoreceptor tyrosine-based inhibitor motif 
(ITIM) domains to negatively regulate PMN signal transduction pathways. ITIM 
phosphorylation by Src family kinases (Hck, Fgr and Lyn) recruits SH2 domain-containing 
phosphatase (SHP) 1 and 2 as well as SH2 domain-containing inositol phosphatase (SHIP) 
1 and 2 that dephosphorylate substrates of ITAM mediated activating signaling pathways in 
order to down-regulate PMN functional responses. Therefore, several ITIM containing 
immunoreceptors have been shown to play key roles in negative regulation of PMN 
trafficking (Fig. 1).  
 
SIRP receptors 
Phagocytes, including PMN, express the ITIM containing protein signal regulatory 
protein  (SIRP) the counter ligand for the widely expressed membrane receptor CD47. 
SIRP also binds soluble surfactant A and D, innate immune system collectins (collagen-
containing C-type lectins). While mAbs to SIRP and soluble CD47 have been shown to 
decrease PMN transepithelial migration [22], more recently it has been demonstrated that 
SIRP mutant mice (which express the extracellular domain of SIRP but not the 
  
 
This article is protected by copyright. All rights reserved. 
 
12 
cytoplasmic ITIM signaling domain) have increased PMN migration in a uric-acid induced 
peritonitis model of sterile inflammation [23].  
 
Siglec receptors 
Sialic acid binding Ig-like lectins (Siglecs) are another family of ITIM containing 
immune receptors expressed by human and murine PMN. In human PMN, engagement of 
Siglec 5 and Siglec 9 by sialylated ligands induces ITIM phosphorylation, recruitment of 
SHP-1 and SHP-2 phosphatases and down-regulation of PMN activator signaling pathways 
[24]. As such, PMNs deficient in Siglec E (the murine paralog of Siglec 9) show accelerated 
recruitment to the lung upon intranasal administration of LPS. This increase in PMN 
trafficking is mediated by inhibition of CD11b outside-in signaling downstream of 
engagement of Siglec E by sialylated fibrinogen [25].  
 
PIR receptors 
The paired immunoglobulin receptor (PIR-B) is another ITIM containing 
immunoreceptor that functions as a negative regulator of integrin-mediated migration in 
PMN. Src family kinases Hck and Fgr phosphorylate tyrosine residues of the PIR-B ITIM 
domain thereby activating it and suppressing PMN activation. As such, treatment of PMN 
deficient in PIR-B with cytokines (MIP-1/CCL3, and MIP-2/CXCL2) results in enhanced 
intracellular calcium mobilization, increased ERK1/2 activation, increased actin 
polymerization and enhanced migratory capacities [26, 27].  Another PMN inhibitory 
receptor, PILR (paired immunoglobulin-like type 2 receptor ), contains two ITIM domains 
that recruit SHP-1 and SHP-2. PILR binds in cis to PMN expressed sialyloglycoproteins to 
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negatively regulate chemoattractant-triggered activation of PMN by 2 integrins [28]. 
Increased activation of Rap1 following fMLF stimulation of Pilr-/- PMN compared to wild type 
PMN has also been reported, suggesting that PILR down-regulates GPCR mediated 
integrin activation. As such, Pilr-/- mice have increased PMN recruitment in vivo in a 
thioglycolate-induced sterile peritonitis model [28]. 
 
Src Family Tyrosine Kinases and Phosphatases signal downstream of ITIM domains 
In addition to inhibitory signaling mechanisms orchestrated through phosphorylation 
of ITIM domains, protein phosphatases also counterbalance PMN signaling activation and 
play a central role in inhibiting PMN migration. Tyrosine phosphorylation is one of the earliest 
consequences of PMN cell surface receptor activation [29]. The Src family tyrosine kinases 
have been implicated in a number of GPCR signaling pathways that propagate downstream 
signals in a positive fashion resulting in activation of PMN processes including migration, 
phagocytosis and degranulation [30, 31]. However, the role of Src kinases in PMN activation 
is somewhat controversial in that it has also been reported that Src kinases can also act as 
negative regulators of PMN function. PMN from double knockout Hck/Fgr mice displayed 
significantly higher peak Ca2+ flux following stimulation with chemokines including CCL3, 
CXCL1 and CXCL2 and IL-8 [27]. In addition, double mutant Hck-/-Fgr-/- PMN demonstrated 
increased ERK1/2 activation, increased F-actin polymerization and increased chemotaxis in 
vitro to CCL3 and CXCL2. Similar to results observed in vitro, increased PMN trafficking of 
Hck-/-Fgr-/- PMN was observed in vivo using a thioglycolate induced model of sterile 
peritonitis, suggesting that Hck and Fgr signal through ERK1/2 to dampen PMN migratory 
responses to agonists of both CXCR2 and CCR1 [27]. In support of this negative regulation 
of PMN trafficking by Src kinases, other studies have shown that Lyn negatively regulates 
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integrin mediated PMN adhesion through ITIM domain phosphorylation of inhibitory 
immunoreceptors (SIRP1 and PIR-B) and subsequent recruitment of SHP-1. Therefore, 
reduced tyrosine phosphorylation of both SIRP1 and PIR-B following engagement of 2 
integrins in Lyn-/- PMN results in reduced recruitment of SHP-1 and a hyper-adhesive/hyper-
responsive phenotype [15]. In keeping with this, it has also been reported that PMN and 
macrophages from mice with a point mutation in Shp-1, that reduces expression of SHP-1 by 
90%, display a hyper-adhesive phenotype [15, 32]. Abram et al. demonstrated that selective 
deletion of SHP-1 in murine PMN resulted in a hyper-activated PMN phenotype 
characterized by increased activation of ERK1/2, Src-Family kinases and Syk as well as 
spontaneous PMN mediated cutaneous paw inflammation [33]. As in mice, increased PMN 
trafficking to the skin resulting in neutrophilic dermatoses is also seen in humans with a 
spontaneous mutation in the Ptpn6 gene [34]. Thus, deficiency of PTPN6/SHP-1 or impaired 
recruitment of SHP-1 to ITIM containing immunoreceptors in Lyn-/- PMN results in hyper-
responsiveness, increased integrin ligation and increased PMN migration.   
The protein-tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed 
phosphatase that is activated upon exposure to pro-inflammatory mediators including TNF. 
Activated PTP1B can in turn act as a common negative regulator of NFB, Akt and MAPK 
activities. In keeping with its role as a negative regulator of immune cell function Ptp1b KO 
mice exhibited higher accumulation of PMN (as measured by myeloperoxidase (MPO) levels 
and severity of edema) in the ear in response to LPS or Zymosan [35] and in the lungs in 
response to P. aeruginosa [36]. Similarly, in a respiratory syncytial virus (RSV) model of lung 
inflammation, loss of PTP1B expression resulted in changes in cytokine signaling, elevated 
PMN accumulation and increased damage and disruption of the epithelial cell barrier [37].   
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Immune signaling through small GTPases regulates PMN trafficking 
 PMN trafficking is facilitated by rapid chemokine-induced generation of cellular 
phosphoinositol phosphate gradients. Agonist-activated phosphoinositide-3 kinases (PI3Ks) 
trigger activation of lipid second messengers PtdIns(3,4,5)P3 and PtdIns(3,4)P2. These 
lipids recruit and activate PI3K effectors including guanine nucleotide exchange factors 
(GEFs), GTPase activating proteins (GAPs) and Rho family small GTPases. Rho family 
small GTPases expressed by PMN include Rac proteins (Rac1, Rac2 and RhoG), RhoA and 
Cdc42. Certain small GTPases are known to negatively regulate PMN migratory responses. 
In general, the activation of Rho GTPases is positively regulated by GEFs and negatively 
regulated by GAPs. Thus, RhoA is reported to act as a rheostat suppressing premature PMN 
activation. In keeping with this, depletion of RhoA in PMN leads to increased PMN 
chemotaxis towards 2 integrin independent stimuli including CXCL1 [38]. Increased 
trafficking of RhoA/B deficient PMN was also observed in vivo following sterile inflammation 
induced by thioglycolate [38]. ARHGAP25 is a Rac-specific GAP expressed by PMN, and 
similar to what was found for RhoA, it has been reported that loss of ARHGAP25 expression 
leads to a pro-inflammatory phenotype with increased PMN Rac activation and elevated 
transmigration into inflamed tissues [39]. Bcr and Abr are GAPs that contain binding sites for 
a number of signal transduction proteins including tyrosine kinases, serine/threonine kinases 
and scaffolding proteins. Interestingly, increased PMN accumulation in the lungs of double 
mutant Abr-/- Bcr-/- mice following LPS injection has been reported [40], suggesting that Bcr 
and Abr are PMN cell signaling mediators that down regulate PMN trafficking responses. 
 
Signaling through second messengers and GPCRs regulates PMN trafficking 
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 PI3K mediated generation of PtdIns(3,4,5)P3 and Rac activation at the leading edge 
of migrating PMN is counter-balanced by the activity of PtdIns(3,4,5)P3 phosphatases, SH2 
domain containing inositol phosphatase 1 (SHIP-1) and phosphatase tensin homologue 
(PTEN) which, convert PtdIns(3,4,5)P3 to PtdIns(3,4)P2 at the back of migrating cells. In 
keeping with its role as a negative regulator of PMN activation, Subramanian et al. 
demonstrated that in response to chemoattractants (including IL-8, C5a and fMLF), PTEN 
deficient PMN demonstrated enhanced Akt activation, prolonged F-Actin activation, 
increased membrane ruffling and increased chemotaxis across transwell support filters [41]. 
In addition, loss of PTEN led to an increase in PMN recruitment to the peritoneum in 
response to inflammatory stimulants including thioglycolate and E. coli. Further in vivo 
studies used intravital microscopy to show that disruption of PTEN on PMN increased PMN 
rolling velocity and PI3K dependent PMN recruitment to the cremaster muscle in response to 
various stimuli including fMLF, TNF- and CXCL2. Increased PMN emigration efficiency to 
the cremaster muscle in the more physiologically relevant setting of ischemia/reperfusion 
injury was also observed in myeloid specific PTEN KO mice compared to WT mice [42]. 
Enhancement of PTEN null PMN trafficking was also observed in a mouse model where lung 
inflammation was induced by intra-tracheal instillation of E. coli (one of the most common 
pathogens in neutropenia related pneumonia). Further, specific increases in PtdIns(3,4,5)P3 
and Akt phosphorylation as well as increased PMN trafficking to the lungs were also 
reported in PTEN deficient PMN compared to WT PMN in a neutropenia-associated 
pneumonia model [43].   
Another second messenger-mediated binding interaction that down-regulates PMN 
trafficking is binding of adenosine to its GPCR (Adenosine Receptor A(2A)AR). Adenosine is 
an an extracellular messenger that plays a protective role in acute inflammation and 
promotes wound healing through down-regulation of PMN activity [44]. Activation of 
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A(2A)AR causes a reduction in PMN motility and as such depletion of A(2A)AR in vivo leads 
to increased PMN trafficking to the airways and increased lung inflammation in response to 
aerosolized ragweed allergen [45]. 
Binding of the glucocorticoid-regulated protein Annexin A1 (Anxa1) to its GPCR 
(formyl peptide receptor type 2/lipoxin A4 receptor, FPR2/ALX) has also been identified as a 
mechanism for limiting the scope of an inflammatory response. As such, administration of 
Anxa1 to mice results in potent inhibition of PMN egress from the microcirculation [46]. 
Corroborating evidence of the inhibitory role of Anxa1 was provided by in vitro studies 
demonstrating inhibition of PMN transmigration across endothelial cells upon treatment with 
Anax1. Consistent with these data, PMN from Anxa1 deficient mice have increased 
CD11b/CD18 surface expression and increased chemotactic responses compared to WT 
PMN [47]. Binding of the anti-inflammatory ligand lipoxin A4 to FPR2/ALX also inhibits PMN 
chemotaxis, adhesion and transmigration across vascular endothelium [48]. Further 
evidence for FPR2/ALX acting as an anti-inflammatory GPCR was provided using mice 
lacking FPR2/ALX. These mice had increased inflammation associated with a marked 
increase in PMN adherence and emigration in the mesenteric microcirculation following 
ischemia reperfusion injury and as well as an increased acute response to carrageenan-
induced paw edema compared to WT FPR2/ALX expressing PMN [49]. Given the number of 
studies demonstrating that PMN FRP2/ALX can be targeted to negatively regulate PMN 
trafficking and PMN inflammatory function, signaling through this GPCR is an area that is 
currently being investigated for anti-inflammatory therapeutics [50]. 
 
Immune signaling by JAK-STAT regulates PMN trafficking 
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Cytokine stimulation of immune cells activates the Janus kinase signal transducer 
and activator of transcription (JAK-STAT) pathway mediating a range of biological processes 
including PMN trafficking. JAK-STAT pathways are therefore regulated at many steps 
through distinct mechanisms including tyrosine phosphatases, protein inhibitor of activated 
STAT (PIAS) and SOCS. Negative regulation of PMN trafficking by members of the SOCS 
family has been previously described. Mice with myeloid specific deletion of SOCS3 have 
elevated STAT 3 activation and more extensive PMN infiltration into the cerebellum and 
brainstem compared to WT mice in an experimental autoimmune encephalomyelitis model 
[51]. Similarly, using an in vivo model of inflammatory arthritis Wong et al. demonstrated that 
deletion of SOCS3 from PMN results in more pronounced joint inflammation characterized 
by increased numbers of PMN in the inflamed synovium [52].  
 
Cytokine-mediated suppression of PMN trafficking 
Negative regulation of PMN trafficking is also mediated directly by cytokine triggered 
immune signaling. In response to Staphylococcus aureus, human PMN engage IL-20 
resulting in modification of actin polymerization and inhibition of a broad range of actin 
dependent functions. Using an in vitro model of PMN migration, Gough et al. recently 
demonstrated that IL-20 actively inhibits PMN transmigration across bronchoepithelial cells 
in an ERK1/2 dependent fashion [53]. A similar IL-20 mediated inhibition of PMN trafficking 
has been reported in vivo in a mouse model of corneal healing [54]. 
 
Immune signaling mediated regulation of PMN Phagocytosis 
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 Following trafficking to a site of infection, PMN are the first immune cells to encounter 
and subsequently engulf invading pathogens. As such phagocytosis is central to the 
microbiocidal function of PMN and, as with other PMN effector functions including maturation 
and migration, the process of PMN phagocytosis is also highly regulated by a variety of 
intracellular signaling cascades. PMN phagocytosis requires reorganization of the actin 
cytoskeleton, a process that depends on small GTPases, particularly Rac [55]. There are 
many studies from transgenic mice, and human PMN demonstrating that most, if not all, 
PMN functions including phagocytosis are subject to regulation by Rho family small 
GTPases. To date, two PtdIns(3,4,5)P3 activated Rac GAPs, ARHGAP15 and ARHGAP25, 
have been shown to drive Rac-inactivation in myeloid cells. It has also been demonstrated 
that ARHGAP15-deficient PMN display increased Rac-dependent F-actin reorganization as 
well as increased phagocytosis and pathogen killing [56].
 
As such, overexpression of 
ARHGAP25 in an FcRIIa-expressing cell line (COSphoxFcR) significantly decreased 
phagocytosis of serum-opsonized yeast particles. In a promyelocytic cell line (PLB-985) 
differentiated to a PMN-like phenotype, silencing ARHGAP25 significantly enhanced 
complement-mediated phagocytosis of opsonized yeast particles. ARHGAP25-mediated 
increases in phagocytosis were also reported in primary macrophages [57]. These 
phenotypes suggest a potential role for both of these Rac GAPs in down regulating PMN 
phagocytosis in order to promote pathogen clearance while minimizing PMN-inflicted tissue 
damage (Fig. 2).  
In addition to F-actin mediated regulation of phagocytosis, suppression of 
phagocytosis downstream of phosphatase activity has also been reported. PTEN is a 
phosphatase that negatively regulates PtdIns(3,4,5)P3 therefore acting as a negative 
regulator of several PMN effector functions including phagocytosis. Li and colleagues 
reported that PTEN null PMN showed enhanced bacteria killing in a pneumonia model due 
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to increased phagocytic capacity [43]. Another phosphatase, the ubiquitous tyrosine 
phosphatase PTP1B has been shown to negatively regulate PMN function. In a P. 
aeruginosa infection model, Ptp1b-/- mice displayed enhanced bacterial clearance 
accompanied by increased PMN infiltration in the lungs, suggesting increased phagocytosis 
in the absence of PTP1B [36]. However, further analysis dissecting the individual roles of 
PMN and macrophages in bacterial clearance is necessary in order to conclude PTP1B 
negatively regulates PMN phagocytosis. 
Release of anti-inflammatory cytokines during later stages of an immune response 
also serves to dampen PMN activation and prevent detrimental damage to host tissues. 
Recently Gough et al. found that IL-20 inhibits PMN phagocytosis, degranulation and 
migration by modifying actin polymerization in an S. aureus model of infection [53]. IL-20 
signals through two different receptor complexes made up of heterodimers of the common 
IL-20RB subunit and either IL-20RA (complex type I) or IL-22RA (type II). While PMN from 
peripheral blood of healthy donors expressed only IL-22RA, exposure to S. aureus resulted 
in increased expression of IL-20RB in IL-8 or TNFα primed PMN in vivo and in vitro. 
Following S. aureus infection, treatment with IL-20 reduced intracellular bacterial killing in 
primed PMN, by impairing phagocytosis [53]. IL-20 induced phosphorylation of ERK1/2 but 
not p38 MAPK, and inhibition of ERK1/2 signaling restored the phagocytic ability of TNFα 
primed PMN suggesting that IL-20 inhibits PMN phagocytosis in an ERK1/2 dependent 
fashion.  
 
Small GTPase mediated regulation of PMN ROS production 
Following migration into inflamed tissues and phagocytosis, PMN destroy engulfed 
pathogens in part through the generation of an oxidative burst (reviewed in full elsewhere 
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[58]) However, given its destructive potential, ROS production by PMN is tightly regulated. 
PMN ROS production requires complex cytoskeleton rearrangement facilitated by small 
GTPases of the Rho family (Rac, Rho and Cdc42). As such Rho family GTPases are 
important negative regulators of the PMN oxidative burst.  Adherence of PMN to a variety of 
extracellular matrix proteins results in a delay in the formation of ROS. This suppression of 
the oxidative burst represents a protective mechanism to prevent tissue damage by PMN as 
they move through tissues to reach sites of inflammation. This adhesion mediated regulation 
of NADPH oxidase is in part mediated by the small GTPase Rac2. It has been reported that 
activated PMN integrins suppress Rac2 activation and assembly of a functional NADPH 
oxidase complex. This inhibitory effect is also associated with tyrosine phosphatase 
mediated decreases in Y174 phosphorylation of the membrane associated Rho/Rac guanine 
nucleotide exchange factor (GEF), Vav-1 [59]. These data therefore suggest that Vav1 is an 
important link between G protein-coupled chemoattractant receptors and Rac2 mediated 
activation of NADPH oxidase.  The TNF induced protein 8 family member TIPE2 also 
regulates the PMN oxidative burst by binding to and blocking Rac GTPases. As a result of 
this inhibitory interaction, compared to WT PMN, Tipe2-/- PMN exhibited enhanced 
intracellular and extracellular ROS production in response to stimulation with fMLF or Listeria 
monocytogenes [60]. Bcr is another Rac1/Rac2 GAP implicated in signaling events that 
down-regulate PMN ROS production and it has been reported that PMN from Bcr-/- mice 
have increased Rac mediated reactive oxygen metabolite production in response to fMLF 
[61]. Arap3 is a PI3K regulated RhoA GAP that also signals to down-regulate PMN 
activation. In keeping with this, an increase in 2 integrin/adhesion dependent ROS 
generation in PMN deficient in Arap3 has been reported [62].Finally, enhanced ROS 
generation associated with augmented translocation of the gp91phox-p22phox complex, the 
phagocyte oxidase component p47phox and the atypical protein kinase C to the plasma 
  
 
This article is protected by copyright. All rights reserved. 
 
22 
membrane has been reported in RhoA/B deficient PMN, further demonstrating the 
suppressive role of small GTPases on generation of the PMN superoxide burst [38] (Fig. 2).  
 
ITIM containing immunoreceptors regulate PMN ROS generation 
Similar to other important PMN effector functions (discussed above), PMN ROS 
production is also subject to negative regulation by ITIM-domain containing 
immunoreceptors. The ITIM domain containing inhibitory receptor CD300a is up-regulated 
by inflammatory stimuli on human PMN and reduces Fc receptor (CD32a) mediated ROS 
production by inhibiting Ca2+ flux [63]. Clec12 is another ITIM-containing C type lectin 
receptor expressed by PMN that recruits SHP-1 and SHP-2 to negatively regulate Syk 
signaling. Clec12 is also a negative regulator of PMN ROS production and it has been 
demonstrated that monosodium urate crystals (MSU)-induced p40phox phosphorylation and 
subsequent ROS generation is increased in the absence of Clec12 signaling [64]. 
Glycophorin A, a sialylated erythrocyte membrane glycoprotein, engages PMN via the ITIM-
containing inhibitory receptor Siglec 9 to suppress PMN activation and down-regulate the 
oxidative response [65]. Similarly, murine PMN lacking Siglec E have an enhanced oxidative 
burst following stimulation compared to WT PMN [66]. The ITIM containing immunoreceptor 
PIR-B also plays a role in the regulation of PMN activation and inflammatory function with 
PIR-B deficient PMN displaying increased ROS production compared to PMN from WT mice 
[26]. Lastly, CEACAM-1 (CD66a) is the only ITIM domain containing carcinoembryonic 
antigen-related cell adhesion molecule (CEACAM) expressed by PMN. LPS triggers initial 
phosphorylation of Syk followed by CEACAM-1 mediated recruitment of SHP-1 resulting in 
inhibition of IL-1 production and negative fine-tuning of the immune response. As such, 
PMN from Ceacam-1-/- mice challenged with LPS exhibit an augmented oxidative burst [67]. 
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Given the requirement for PtdIns(3,4,5)P3 during the oxidative burst, it has been 
reported that the phosphatase PTEN, which converts PtdIns(3,4,5)P3 back to PtdIns(3,4)P2,  
is a physiological suppressor of chemoattractant induced PMN ROS release.  As such, 
increased PtdIns(3,4,5)P3 signaling in PTEN deficient PMN corresponds with enhanced Akt 
phosphorylation, augmented actin polymerization as well as increased fMLF-triggered 
superoxide production [41]. In addition to the role of Src family kinases in ROS production, it 
has also been reported that Btk, a member of the Tec-family kinases involved in Toll-like 
receptor (TLR) signaling, down-regulates the amplitude of the PMN oxidative burst. 
Therefore, following TLR stimulation PMN from Btk-/- mice had increased activation of key 
signaling molecules involved in NADPH oxidase activation, increased targeting of Rac-2 to 
the plasma membrane, increased PI3K activation and increased ROS release [68]. 
 
Negative regulation of PMN degranulation 
 PMN granules contain large amounts of antimicrobial peptides, proteases, respiratory 
burst oxidases as well as membrane bound receptors and adhesion receptors that allow 
PMN to rapidly respond to and destroy invading pathogens. As tissue-damaging effects of 
PMN are dependent on the release of microbiocidal PMN granule contents, degranulation is 
a highly regulated process subject to both positive and negative regulation. Bcr and Abr, are 
two GTPases-activating proteins (GAPS) with activity towards Rho family GTPases that 
have been reported to negatively regulate PMN function in vivo. Cunnick et al showed these 
two proteins share some overlapping functions while also performing distinct functions [40]. 
BM PMN from double KO mice (Abr-/-Bcr-/-) have elevated levels of activated Rac1 and Rac2 
in response to fMLF and cytochalasin B, leading to increased MPO and elastase release 
compared with WT PMN. However, lactoferrin release, gelatinase release and CD11b 
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surface expression did not differ between Abr-/-Bcr-/- PMN and WT PMN, indicating that 
exocytosis of primary granules, but not secondary granules, tertiary granules, or secretory 
vesicles are negatively regulated by Bcr and Abr [40]. 
There is abundant evidence that Src family kinases play a pivotal role in PMN 
degranulation. C-Terminal Scr kinase (Csk) is a regulator of Src kinases that contributes to 
the control of acute inflammation in vivo through phosphorylation of C-terminal inhibitory 
tyrosine residues [69]. In a mouse model, Csk deficiency in granulocytes (Csk-GEcre), 
results in hypersensitivity to LPS, increased integrin-dependent adhesion, and exaggerated 
spontaneous and adhesion-dependent degranulation of secondary granules as measured by 
lactoferrin release [70]. In Csk deficient PMN, crosslinking of integrins or Fc receptors leads 
to increased Hck activity that induces hyper-phosphorylation of Syk, paxillin, and cortactin 
which promotes polymerization and rearrangement of the actin cytoskeleton. This suggests 
that Csk suppress exocytosis of secondary granules through negative regulation of 
cytoskeletal remodeling downstream of Fc receptors and integrin activation [70].  
Cytokine mediated inhibition of PMN phagocytosis has also been reported. 
Specifically, exocytosis of tertiary (gelatinase) granules in response to S. aureus was 
inhibited by IL-20 in TNF-primed PMN [53]. Tertiary granules are more highly associated 
with actin than primary and secondary granule populations. The regulatory mechanism of IL-
20 in TNF-primed PMN is dependent on ERK1/2 activation and F-actin polymerization. 
These recent studies highlight the need for increased understanding of negative regulation 
of PMN activation/resolution of inflammation downstream of host-derived cytokines such as 
IL-20.  
 
Negative immune regulators of PMN Apoptosis 
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To achieve and maintain homeostasis, circulating PMN die via constitutive apoptosis 
and are cleared by macrophages in the liver, spleen and BM. Given the short half-life of 
PMN, suppression of apoptosis is also essential to facilitate the extended PMN life span 
observed in the tissues during infection/inflammation. Several agents that prime or activate 
human PMN including, cytokines, GM-CSF, C5a, LPS, InsP6 and LTB4 are also reported to 
prolong PMN survival and down-regulate apoptosis [71]. In particular, PI3K/Akt signaling 
plays a pivotal role in PMN survival/suppression of apoptosis. Akt-mediated phosphorylation 
inactivates caspase-9 and stops the pro-apoptotic Bcl-2 family member Bax from associating 
with mitochondria [72]. In addition, inactivation of the Akt target GSK3 prevents 
phosphorylation, ubiquitination and proteosomal degradation of the pro-survival Bcl-2 family 
member Mcl-1 (Fig. 2) [72]. Mechanistically, it has been reported that in apoptotic PMN, 
accumulated ROS inhibits actin-mediated-PI3K-dependent PtdIns(3,4,5)P3 generation, thus 
blocking Akt activation and allowing apoptosis to proceed [73]. Proliferating cell nuclear 
antigen (PNCA) also functions as a PMN anti-apoptotic mediator that binds constitutively to 
pro-caspases-3, -8 and -9 and blocks their proteolytic processing and activation [74]. 
Elevated levels of the second messenger cyclic AMP can also prolong PMN lifespan by 
delaying apoptosis. Though the exact mechanism behind this has yet to be fully elucidated, it 
has been reported that increased intracellular cAMP levels delay PMN apoptosis via a 
transcriptionally independent pathway, independent of PI3K activity that involves inhibition of 
caspase 3 activation and a loss in mitochondrial potential. Another signaling mechanism 
employed by PMN to delay apoptosis is augmenting production of the second messenger 
PtdIns(3,4,5)P3 and thus, increasing Akt activation. As such, depleting PTEN increases 
PtdIns(3,4,5)P3 levels, dramatically delays spontaneous apoptosis of PMN in vitro [75], and 
reduces apoptosis of PMN in inflamed alveolar air spaces [43]. The Src family kinase 
member Lyn is also an important tyrosine kinase for transducing anti-apoptotic signaling in 
PMN [76]. ITIM mediated signaling also regulates PMN apoptosis. In particular binding of 
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CD47 to SIRP induces ITIM phosphorylation and recruitment of SHP-1 and SHP-2 
ultimately resulting in the inhibition of PMN apoptosis [77]. As such, increased PMN surface 
expression of CD47 is associated with a delay in apoptosis and poor prognosis in non-small 
cell lung cancer patients [78]. Finally, recent studies have demonstrated that sialylated 
erythrocyte surface glycans engage the inhibitory immunoreceptor Siglec 9 on circulating 
PMN to suppress activation and apoptosis [65].  
 
Inhibition of PMN NET release 
Neutrophil extracellular trap (NET) release represents an additional PMN 
extracellular antimicrobial function that can also lead to an alternative form of PMN cell death 
(NETosis) that is distinct from necrosis or apoptosis. Negative regulation aimed at 
dampening NET formation remains largely unstudied despite recognition of the contribution 
of NETs to vascular damage and autoimmunity [79, 80]. However, it would be logical to think 
that ITIM mediated negative regulation of NADPH-dependent ROS production and 
degranulation of primary granules would also suppress NET formation (Fig. 2). Signal 
inhibitor receptor on leukocytes-1 (SIRL-1) is an inhibitory receptor, exclusively expressed in 
myeloid cells, that contains two canonical ITIMs essential for its inhibitory function. While the 
endogenous ligands for SIRL-1 are yet to be identified, cross-linking of SIRL-1 has been 
shown to dampen MEK-ERK signaling and suppress spontaneous NET release in PMN from 
individuals with systemic lupus erythematosus (SLE) [81]. Moreover, ligation of SIRL-1 also 
reduces NET formation in PMN from control donors when incubated with plasma from SLE 
patients [81]. In addition, NET formation induced by opsonized S. aureus, and monosodium 
urate is suppressed by SIRL-1 [82]. In contrast, cross-linking of SIRL-1 does not reduce NET 
formation when human PMN were exposed to non-opsonized S. aureus or to the TLR4 
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agonist LPS, indicating SIRL-1 regulates NET formation only in response to specific signals. 
Importantly, phagocytosis and ROS production remain intact following crosslinking of SIRL-
1. Therefore, SIRL-1 specifically regulates cellular pathways required for extracellular NET 
formation, but not intracellular microbial killing [82].  
The ITIM containing immunoreceptors Siglec 9 and Siglec 5 also deliver inhibitory 
signals that dampen NET formation by human PMN. As discussed above, PMN activation in 
the circulation is suppressed by erythrocyte sialoglycoproteins interacting with Siglec 9 [65]. 
In addition, increased concentrations of erythrocytes significantly reduced extracellular DNA 
release by PMN in response to PMA. Further, this effect was lost when the side chains of the 
terminal sialic acids were selectively and specifically modified to reduce erythrocyte binding 
to Siglec 9, proving a specific sialic acid mediated interaction. Incubation of PMN with 
platelets resulted in inhibition of other PMN functions including apoptosis [83]. However, 
whether or not platelets can contribute to dampening NET formation through the interaction 
of their rich sialic acid covered surfaces with PMN Siglec 9 has not yet been reported. Siglec 
9 also binds high molecular weight hyaluronan (HMW-HA), which is abundantly expressed in 
many tissues including synovium, skin, heart valves, etc. While low molecular weight 
hyaluronan (LMW-HA) is released under inflammatory conditions and can induce pro-
inflammatory cytokines, cell proliferation and angiogenesis, HMW-HA mitigates the 
inflammatory response by binding CD44 and Siglec 9 on PMN. The interaction of HMW-HA 
with CD44 reduces NET formation induced by PMA. Moreover, the interaction of HMW-HA 
with Siglec 9 increases SHP-1 recruitment and suppresses not only NET formation, but also 
apoptosis and oxidative burst by PMA-stimulated PMN as mentioned above [84]. 
Interestingly, some human pathogens, including Group A (GAS) and Group B (GBS) 
Streptococcus, interact with PMN Siglecs through their capsular polysaccharide components 
to down-regulate PMN activation and increase the rate of bacterial survival [84-87]. GAS 
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expresses a HMW-HA capsule and GBS displays terminal sialic acids, both of which are 
able to engage Siglec 9 and block NET formation [84, 86]. GBS also binds to Siglec 5 
through  protein expressed in its capsule, resulting in inhibition of NET formation 
independent of sialic acid binding [85]. Pseudomonas aeruginosa, an opportunistic human 
pathogen, does not synthetize sialic acid but it is able to absorb sialoglycoproteins from host 
serum that it uses to bind to PMN Siglec 9 thus suppressing PMN ROS release and NET 
formation [87]. 
 Another family of proteins that play multiple roles in regulating PMN effector functions 
are the semaphorins. Semaphorins are transmembrane proteins that bind several receptors, 
i.e. plexins B1/B2 and CD72 [88]. Recently it has been reported that binding of PMN 
expressed semaphorin 4D (SEMA4D) to its endothelial expressed receptor Plexin B2 results 
in activation of the SEMA4D intracellular domain, decreased Rac activation and inhibition of 
anti-PMN cytoplasmic-induced oxidative burst and NET release [89].  
 
 
Conclusions 
PMN exert important effector functions in order to provide host defense against 
bacterial and fungal infections. Activation of PMN functions is initiated by receptor-ligand 
binding events and modulated by an array of intracellular signaling pathways. Insufficient 
PMN activity renders the host susceptible to repeated infections, which can be life-
threatening. Yet, dysregulated PMN activation can result in excessive collateral damage to 
the host, as exemplified by a range of inflammatory and autoimmune diseases. Therefore, 
PMN activation must be tightly regulated to protect the host from pathogen assaults without 
inducing detrimental inflammation and tissue damage.  
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This review provides an overview of immune signaling pathways that negatively 
regulate PMN function with a particular emphasis on PMN regulation through ITIM-bearing 
inhibitory receptors (Table 1). Despite the existence of a number of studies describing 
negative regulation of PMN function downstream of cell surface receptor engagement, many 
questions remain. For example, it is not well understood how single classes of PMN 
inhibitory receptors can differentially respond to various extracellular stimuli to specifically 
downregulate discrete PMN effector functions. Similarly, it is yet to be determined how 
different PMN inhibitory receptors can exert discrete functional responses to the same 
extracellular signals. While we have focused on suppression of PMN functions by intrinsic 
pathways it is also known that PMN activation in inflamed tissues is regulated by specialized 
pro-resolution mediators (secreted by epithelial and immune cells) including resolvins, 
protectins and maresins which favor deactivation of PMN and the resolution of inflammation. 
The identification of new drug targets aimed at downregulating PMN activation may be 
useful for reducing the uncontrolled inflammation that is characteristic of septic shock, 
chronic inflammatory conditions and autoimmune diseases. Therefore, increased 
understanding of the mechanisms that negatively regulate PMN function is likely to have 
profound biologic and pharmacologic relevance. 
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Figure legends 
 
Figure 1. Schematic representation of ITIM mediated inhibition of PMN trafficking. 
Phosphorylation of intracellular ITIM domains by Src kinases leads to recruitment of SHP1/2 
and SHIP1/2 followed by subsequent inhibition of Syk kinase-mediated PI3K activation, 
CD18/CD11b signaling, actin polymerization, ERK1/2 activation, Rap activation and Ca2+ 
mobilization, decreased generation of PtdIns(3,4,5)P3 and decreased Akt activation leading 
to reduced PMN activation and reduced PMN trafficking [16, 26-29, 33-35, 42]. 
.
 
  
 
This article is protected by copyright. All rights reserved. 
 
40 
 
Figure 2. Different effectors negatively regulate PMN functions. GTPase-activating 
proteins (GAPS), have been shown to suppress PMN functions such as phagocytosis, ROS 
production, and degranulation by inhibiting the activation of Rac and F-actin polymerization 
[39, 40, 56, 57, 61]. Vav-1 and TIPE-2 also inhibits Rac activation and therefore, suppress 
ROS production [59, 60]. Phosphatases such as PTP1B and PTEN negatively regulates 
phagocytosis [36]. PTEN also regulates ROS production by regulating the availability of 
PtdIns(3,4,5)P3 [41]. Since it is well described NET formation depends of ROS production it 
is possible that negative regulators of ROS production are also potentially inhibiting 
NETosis. C-terminal kinase inhibits degranulation by phosphorylating the C-terminal 
inhibitory tyrosine residues of Src kinases [69]. PMN apoptosis can be delayed by active Akt 
promoting the inactivation of caspase-9 and therefore the inactivation of the pro-apoptotic 
Bcl-2 family member Bax. In addition, Akt has been described to inactivate GSK3β, 
preventing the degradation of the anti-apoptotic Bcl-2 member Mcl-1 [72].  
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Effector PMN Function Gene Reference 
Kinases: 
     Csk Degranulation Csk 70 
     Akt Apoptosis Akt, Pkb, 72, 73, 75 
Src family kinases: 
     Hck Granulopoiesis, Trafficking Hck 27 
     Fgr Trafficking Fgr, Src2 27 
     Lyn Trafficking, Apoptosis Lyn, Jtk8 6, 15,16, 76 
Small GTPases and regulators: 
     RhoA/B Trafficking, ROS Rhoa, Arha; Rhob, Arhb 38 
     Vav1 ROS Vav1 59 
     Tipe2 ROS Tnfaip8l2 60 
     Arap3  ROS Arap3, Centd3 62 
     ARHGAP25  Trafficking, Phagocytosis Arhgap25 39, 57 
     ARHGAP15  Phagocytosis Arhgap15  56 
     Abr Trafficking, Degranulation Abr 40 
     Bcr Trafficking, Degranulation, ROS Bcr 40, 61 
Phosphatases: 
     Wip1 (PP2Cd) Granulopoiesis Wip1, Ppm1d 20 
     SHP-1 Trafficking, ROS, Apoptosis, NETosis Ptpn6 Hcp, Ptp1c 15, 24, 32-34, 
64, 67, 77, 84 
     SHP-2 Trafficking, ROS, Apoptosis Ptpn11, Ptp2c 24, 66, 77 
     PTP1B Trafficking, Phagocytosis Ptpn1, Ptb1b 35-37 
     PTEN Trafficking, Phagocytosis, Apoptosis Pten Mmac1, Tep1 41-43 
Cytokines and suppressors: 
     IL-20 Trafficking, Phagocytosis Il20 ZCYTO10 53, 54 
    SOCS-3 Granulopoiesis, Trafficking Socs3 7, 8, 51, 52 
 
  Orthologue in 
mouse 
Ligand PMN Function Gene References 
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Inhibitory  Receptors: 
PILRα ND CD99-like protein HSV-1: 
glycoprot B 
Trafficking Pilra  28 
LILRB3 PIR-B MHC-I and class I like 
molecules, 
Angiopoietin-like Protein 2 
Trafficking, 
ROS 
Lilrb3 Pirb 15, 26, 27 
SIRP-α  CD47, SF-A, SF-D Trafficking, 
Apoptosis 
Sirpa 15, 22, 23, 
77 
Siglec 5  Siglec F Sialic acid NETosis Siglec5 85 
Siglec 9  Siglec E Sialic acid, HMW-HA  NETosis, ROS, 
Apoptosis 
Siglec9 25, 65, 66, 
83, 84, 86, 
87 
SIRL-1  Not in mouse ND NETosis Vstm1 81, 82 
CD300a  Phosphatidylserine 
Phosphatidylethanolamine 
ROS Cd300a 
Cmrf35h 
63 
CEACAM1 
(CD66a) 
CEACAM1P CEACAM1 ROS Ceacam1 
Bgp, Bgp1 
67 
CLEC12a Clec12a Uric acid ROS Clec12a 
Dcal2 
64 
Receptors w/o ITIM domains: 
CXCR4 CXCR4 CXCL12 Granulopoiesis Cxcr4 9, 12-14 
CD47 (IAP) CD47 SIRP-α, -, TSP-1, -2 Apoptosis Cd47 78 
A(2A)AR A(2A)AR Adenosine Trafficking Adora2a 
Adora2 
44, 45 
FPR2/ALX FPR2 Lipoxin A4, Annexin A1, 
serum amyloid A, 
Resolvin D1, formylated 
peptides. 
Trafficking Fpr2 48-50 
Semaphorin4D Semaphorin4D Plexin B1/B2, CD72 NETosis Sema4D 89 
ND: not determined 
 
Table 1: Effector molecules and inhibitory receptors found on PMN. Top table shows 
effector molecules playing a role in negative regulation of PMN functions. Bottom table 
shows inhibitory receptors found on PMN. First column shows the most common names 
found on human PMN inhibitory receptors. The second column shows the orthologues found 
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in mouse PMN. All inhibitory receptors possess at least one immunoreceptor tyrosine- based 
inhibitory motif (ITIM). Other receptors without an ITIM domain are able to suppress PMN 
functions.  
 
 
